Govt reduce price of Remdesivir Injection

File No. 37008/2021/Div.VI/NPPA
Government of India
Ministry of Chemicals & Fertilizers
Department of Pharmaceuticals
National Pharmaceutical Pricing Authority

OFFICE MEMORANDUM

This is with reference to the ongoing efforts for enhancement of availability and affordability of ‘Remdesivir injection. On the intervention of the Government, the major manufacturers/marketers of ‘Remdesivir injection’ have reported voluntary reduction in Maximum Retail Price (MRP). The revised prices of major brands of ‘Remdesivir injection 100mg/Vial’ are as follows:

S.No.	Name of the Company	Brand Name	Earlier MRP (Rs.)	Revised MRP
1.	Cadila Healthcare Ltd	REMDAC	2,800/-	899/-
2.	Syngene International Ltd (Biocon Biologics India)	RemWin	3,950/-	2,450/-
3.	Dr. Reddy’s Laboratories Ltd	REDYX	5,400/-	2,700/-
4.	Cipla Ltd	CIPREMI	4,000/-	3,000/-
5.	Mylan Pharmaceuticals Pvt Ltd	DESREM	4,800/-	3,400/-
6.	Jubilant Generics Ltd	JUBI-R	4,700/-	3,400/-
7.	Hetero Healthcare Ltd	COVIFOR	5,400/-	3,490/-

(Dr. Vinod Kotwal)

Member Secretary

To

Drug Controller / Food & Drug Administration of all State / UT Governments for information and compliance

Copy for information to:

1. PPS to Hon’ble Minister (HCF)
2. PPS to Hon’ble Minister of State (HCF)
3. Secretary (Pharma), Gol
4. Secretary (Health),GoI
5. Pr. Health Secretaries (All States/UTs)
6. Drug Controller General (India)

Enter your email address:

Subscribe to faceless complainces